Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Hydrops fetalis panel for lysosomal disorders Lysosomal Diseases Testing Laboratory Thomas Jefferson University United States | 23 | 7 |
|
Lysosomal Diseases Testing Laboratory Thomas Jefferson University United States | 57 | 18 |
|
Lysosomal Storage Disease Panel Molecular Genetics Laboratory London Health Sciences Centre Canada | 77 | 50 |
|
Centogene US, LLC - The Rare Disease Company United States | 829 | 848 |
|
SLC17A5 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 2 | 1 |
|
SLC17A5 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Invitae United States | 971 | 680 |
|
Invitae Skeletal Disorders Panel Invitae United States | 624 | 349 |
|
Invitae Cerebral Palsy Spectrum Disorders Panel Invitae United States | 646 | 420 |
|
Non-Immune Hydrops Fetalis Panel PreventionGenetics United States | 291 | 148 |
|
Lysosomal Storage Disorders Panel PreventionGenetics United States | 242 | 146 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 527 | 338 |
|
Leukodystrophy and Leukoencephalopathy Panel PreventionGenetics United States | 201 | 211 |
|
Invitae Comprehensive Lysosomal Storage Disorders Panel Invitae United States | 87 | 57 |
|
Invitae Mucopolysaccharidoses Plus (MPS+) Panel Invitae United States | 38 | 27 |
|
Sialic Acid Storage Disorder (Salla Disease) via the SLC17A5 Gene PreventionGenetics United States | 2 | 1 |
|
Panel of lysosomal disorders and mucopolysaccharidosis. NGS panel of 102 genes. Genologica Medica Spain | 175 | 102 |
|
Lysosomal Storage Diseases Gene Panel Duzen Laboratories Duzen BBAGUAS Turkey | 50 | 43 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.